$XBI $146.46 (-2.37%) 📉
COVID-19:
$ARCT (-5.82%) - Approval to proceed with phase 2 study.
$NVAX (-9.66%) - Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico
PIPELINE:
$CARA (+0%) - Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus
$HGEN (-21.14%) - Humanigen Secures U.S. Patent for Lenzilumab in Preventing Cytokine Storm and Neurotoxicity Related to CAR-T Cell Therapy
$MYOV (+20.22%) - Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health
FINANCIAL:
$ARVN (+1.38%) - Underwriter's options exercised post data and raise.
Comments